Stryker Completes Acquisition of Amplitude Vascular Systems
Stryker Corporation has finalized its acquisition of Amplitude Vascular Systems, enhancing its peripheral vascular portfolio with next-generation intravascular lithotripsy technology designed for complex arterial disease treatment. The integration aims to improve healthcare outcomes by utilizing innovative CO₂-generated pressure wave technology.
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease.